
Maria L Padilla
Pulmonary Disease · Icahn School of Medicine at Mount Sinai
Credentials: · · ·
History
Research
Chest · 2007 · 240 citations
Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis
Review · European Respiratory Review · 2017 · 232 citations
Acute exacerbations of progressive-fibrosing interstitial lung diseases
Review · European Respiratory Review · 2018 · 152 citations
- PS
17 papers
- AT
12 papers

7 papers · 7 as a resident

6 papers

6 papers
- CH
6 papers
- DY
6 papers
- GS
5 papers
Grants
- 1982–1987
National Heart, Lung, and Blood Institute · K07
Contact PI · $129.1K · Mount Sinai School of Medicine of Cuny
Clinical trials
- 2020–2024
Principal investigator · Completed · Phase 4
Icahn School of Medicine at Mount Sinai
- 2020–2025
Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis
Principal investigator · Active not recruiting · Phase 1, Phase 2
National Jewish Health
- 2009–2014
Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF
Principal investigator · Completed · Phase 3
Duke University
- 2026–2027
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Site PI · Recruiting · Phase 2
Rein Therapeutics



